Impact of renal failure on liver transplantation survival
- PMID: 18455024
- DOI: 10.1016/j.transproceed.2008.02.062
Impact of renal failure on liver transplantation survival
Abstract
Renal failure after orthotopic liver transplantation (OLT) is a common complication (ranging from 12% to 70%) associated with worse outcomes, particularly when it requires renal replacement therapy (RRT). Renal dysfunction is a common scenario among waiting list patients. It can lead to a worse prognosis after OLT, due to an increased incidence of postoperative renal failure. The aim of this study was to analyze the incidence of renal failure after OLT, its relationship to pretransplant renal dysfunction, and its impact on outcomes. We analyzed data collected prospectively from 152 consecutive OLTs in 139 patients performed by the same team from March 2003 to November 2007. Exclusion criteria for 34 cases included transplantation due to acute liver failure, combined liver-kidney transplantation, retransplantation, and patients who died up to 2 days posttransplantation. Based on creatinine clearance (CCr) calculated at the time of OLT, the 118 patients were classified in two groups: group I, normal pre-OLT renal function (CCr > or = 70 mL/min) versus group II, pre-OLT renal failure (CCr < 70 mL/min). Each group was analyzed according to the development of post-OLT renal failure, being classified as subgroup A (normal renal function post-OLT), subgroup B (mild renal impairment post-OLT-serum creatinine level between 2.0 and 3.0 mg/dL or doubled basal value up to 3.0 mg/dL) versus subgroup C (severe renal impairment post-OLT-serum creatinine level > or = 3.0 mg/dL or utilization of RRT). The overall incidence of post-OLT renal impairment was 41.52% with RRT in 22 patients (18.64%). Group II patients showed a greater incidence of post-OLT renal failure when compared with other patients (P < .05), but without a statistical difference when compared according to RRT requirement. Comparison of average hospital stay was similar between groups I and II, and also among its subgroups (A, B, and C, respectively). There was no statistical difference in early (30-day) and 1-year survival rates between groups I and II. Comparing all subgroups for early and 1-year survival, we observed that patients who developed severe renal failure post-OLT (subgroups I-C and II-C) showed worse outcomes compared with other patients (subgroups I-A, I-B, II-A, and II-B), respectively 95.29% versus 69.69% and 86.95% versus 41.66% for early and 1-year survivals (P < .001). In conclusion, our findings suggested that patients who developed severe renal failure post-OLT, independent of pretransplant renal function, showed worse outcomes.
Similar articles
-
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.Hepatology. 2002 May;35(5):1179-85. doi: 10.1053/jhep.2002.33160. Hepatology. 2002. PMID: 11981768
-
Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation.Transplant Proc. 2007 Sep;39(7):2318-9. doi: 10.1016/j.transproceed.2007.07.070. Transplant Proc. 2007. PMID: 17889176
-
Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.Liver Transpl. 2009 Mar;15(3):273-9. doi: 10.1002/lt.21731. Liver Transpl. 2009. PMID: 19243008
-
Renal function outcomes following liver transplantation and combined liver-kidney transplantation.Nat Clin Pract Nephrol. 2007 Sep;3(9):507-14. doi: 10.1038/ncpneph0574. Nat Clin Pract Nephrol. 2007. PMID: 17717563 Review.
-
[Assessment of risk factors in the incidence of hepatic artery thrombosis in a consecutive series of 687 liver transplantations].Ann Ital Chir. 2001 Mar-Apr;72(2):187-205. Ann Ital Chir. 2001. PMID: 11552475 Review. Italian.
Cited by
-
Dexmedetomidine Pretreatment Attenuates Kidney Injury and Oxidative Stress during Orthotopic Autologous Liver Transplantation in Rats.Oxid Med Cell Longev. 2016;2016:4675817. doi: 10.1155/2016/4675817. Epub 2015 Nov 22. Oxid Med Cell Longev. 2016. PMID: 26682005 Free PMC article.
-
Recent advances in liver transplantation for the practicing gastroenterologist.Gastroenterol Hepatol (N Y). 2009 Jun;5(6):443-50. Gastroenterol Hepatol (N Y). 2009. PMID: 20574505 Free PMC article.
-
Role of magnetic resonance cholangiography in biliary complications of orthotopic liver transplantation.Radiol Med. 2010 Oct;115(7):1065-79. doi: 10.1007/s11547-010-0563-7. Epub 2010 Jul 31. Radiol Med. 2010. PMID: 20680501 English, Italian.
-
Conversion from Standard-Release Tacrolimus to MeltDose® Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation.J Clin Med. 2020 Jun 1;9(6):1654. doi: 10.3390/jcm9061654. J Clin Med. 2020. PMID: 32492783 Free PMC article.
-
Role of proenkephalin in the diagnosis of severe and subclinical acute kidney injury during the perioperative period of liver transplantation.Pract Lab Med. 2022 May 6;31:e00278. doi: 10.1016/j.plabm.2022.e00278. eCollection 2022 Aug. Pract Lab Med. 2022. PMID: 35733419 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical